Danielle Conway and Sarra Kayed Jones, your exceptional support doesn’t go unnoticed. It’s your hard work and dedication that keeps THRD running seamlessly, and for that, we are grateful. Happy Administrative Professionals Day! #GOTHRD #NationalAdministrativeProfessionalsDay #administrativeprofessionalsday #thankyou
Third Harmonic Bio
Biotechnology
Advancing the next wave of medicine for inflammatory diseases
About us
Third Harmonic Bio is a clinical-stage biopharmaceutical company developing a highly selective, oral KIT inhibitor for treatment of dermal, respiratory and gastrointestinal inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with mast-cell mediated inflammatory diseases. By inhibiting KIT, we believe we can provide broad symptomatic relief to patients with a range of disorders, including chronic spontaneous urticaria and severe asthma.
- Website
-
https://thirdharmonicbio.com/
External link for Third Harmonic Bio
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2019
Employees at Third Harmonic Bio
Updates
-
Welcome to our new board member Geoffrey McDonough, President and CEO of Generation Bio, to the Third Harmonic Bio team!
-
-
Check out our CEO Natalie Holles describe how we worked our way back into the clinic with our new program to treat mast cell-mediated inflammatory diseases with Brad Loncar at BiotechTV. #urticaria
𝐅𝐫𝐨𝐦 𝐁𝐨𝐬𝐭𝐨𝐧: Third Harmonic Bio is nearing an IND submission to put a new oral KIT inhibitor into the clinic. CEO Natalie Holles describes the road to get here. Full video: https://lnkd.in/gVDsgF3J BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
Our team was on the ground at #AAAAI24 this weekend to catch a number of presentations featuring the latest advances in chronic urticaria and mast cell targeting. THRD is on track to bring our new investigational treatment option into the clinic during the first half of this year.
-
-
We are looking to expand our team with a new Senior Manager of Accounting , who will be responsible for leading and building the operational accounting team. Come join our West Coast #THRDHerd!
-
Wishing a Happy #THRDaversary to Nate Bachtell!!!
-
-
Wishing a Happy #THRDaversary to Nam Doan!
-
-
Happy #THRDaversary to Danielle Conway!
-